11 April 2025
11 April 2025
While Trump announced a three-month ‘pause’ on tariff levies for most countries, China’s tariffs were increased to 125%.
Private equity firm Keensight says it no longer aims to strike a deal for the British medtech due to the ‘current macro-economic backdrop’.
According to Source BioScience, the acquisition is set to “complement” its genomics and multiomics capabilities, broadening its clinical offerings.
The device is designed for intraoperative ablation of the post-lumpectomy cavity during BCS.
The two companies are trimming the time taken for genomic analysis of fungi and bacteria from days to hours.
AI tools are faster at drafting clinical trial documents, but human writers remain indispensable for logical reasoning.
The test is currently available to physicians across the US, excluding New York.
APHA executive director Dr Georges C Benjamin said RFK Jr’s ‘complete disregard for science’ had been evident since his appointment as HHS secretary.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
